To further evaluate the clinical relevance of human CD4+ T-cell responses against C-peptide we asked if CD4+ T-cell responses against full-length C-peptide (PI33-63) could be detected in the peripheral blood of people with, or without, T1D. The gene discussed is CD4; the disease is type 1 diabetes mellitus.